Clinical Trial Update: GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating GD2 CAR T cells for diffuse intrinsic pontine glioma and spinal diffuse midline glioma, and the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Spinal Diffuse Midline Glioma

Drugs mentioned

• GD2-CAR T cells

Snippet

Sponsor: Stanford University | Conditions: Glioma of Spinal Cord, Glioma of Brainstem | Phase 1 | Status: RECRUITING